Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation.
Nakao
A
A
Department of Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Nalesnik
M A
MA
Azhipa
O
O
Ishikawa
T
T
Abu-Elmagd
K
K
Starzl
T E
TE
Murase
N
N
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007422:Intestines / Q000528:radiation effects / Q000637:transplantation*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents